Integral Molecular Revenue and Competitors

Location

#5031

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Integral Molecular's estimated annual revenue is currently $16.3M per year.(i)
  • Integral Molecular's estimated revenue per employee is $137,924

Employee Data

  • Integral Molecular has 118 Employees.(i)
  • Integral Molecular grew their employee count by 4% last year.

Integral Molecular's People

NameTitleEmail/Phone
1
VP Research and DevelopmentReveal Email/Phone
2
VP Sales and Customer RelationsReveal Email/Phone
3
VP Antibody DiscoveryReveal Email/Phone
4
Director Scientific Communications and Public RelationsReveal Email/Phone
5
Director Antibody DiscoveryReveal Email/Phone
6
Director ResearchReveal Email/Phone
7
Director Sales and AlliancesReveal Email/Phone
8
Director Human ResourcesReveal Email/Phone
9
Shipping ManagerReveal Email/Phone
10
Information Technology Operations ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Integral Molecular?

Integral Molecular provides innovative solutions for scientific research and drug discovery applications involving cellular and viral integral membrane proteins. We are committed to using and providing our technologies for the treatment and cure of human disease

keywords:N/A

N/A

Total Funding

118

Number of Employees

$16.3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Integral Molecular News

2022-04-17 - Lonza and Integral Molecular Offer to Enhance Early De ...

Lonza, a CDMO, and Integral Molecular, which focuses on discovering and characterizing antibodies against membrane proteins,...

2022-04-17 - Lonza Early Development Services and Integral Molecular to ...

Integral Molecular is an industry leader in developing and applying innovative technologies that advance the discovery of therapeutics against...

2022-04-17 - Lonza And Integral Molecular Announce New Collaborative ...

Integral Molecular de-risks therapeutic molecules by detecting off-target binding liabilities using their Membrane Proteome Array platform.

2021-07-30 - Integral Molecular Launches Transgene Protein Engineering Platform to Address Challenges in Gene Therapy

PHILADELPHIA, July 30, 2021 /PRNewswire/ -- Integral Molecular, the industry leader in membrane proteins, announces the launch of GeneCanvas, its proprietary protein engineering platform to optimize transgenes and other gene therapy elements. GeneCanvas can achieve 10 to 100 fold increases in ...

2020-11-24 - Integral Molecular Announces Best-in-Class Antibodies Against Complex Oncology Target Claudin 18.2

PHILADELPHIA, Nov. 24, 2020 /PRNewswire/ -- Integral Molecular, the leader in discovering antibodies against multipass membrane proteins, announces fully optimized, high-affinity lead monoclonal antibodies (MAbs) against Claudin 18.2 (CLDN18.2), a structurally complex oncology target overexpre ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17.7M1186%N/A
#2
$28.7M1188%N/A
#3
$38.4M11824%$4.9B
#4
$31.9M118N/AN/A
#5
$31.9M1187%$7.4M